Ind Swift Laboratories delivered strong Q3FY26 results with net profit of ₹1074.18 lakhs versus a loss of ₹86.19 lakhs in Q3FY25, driven by 23% revenue growth to ₹14948.10 lakhs. The Board approved leadership restructuring effective February 1, 2026, with Mr. Navrattan Munjal as Chairman & Whole-Time Director, Mr. Himanshu Jain as Managing Director (Domestic Operations), and Mr. Sahil Munjal as Managing Director (Global Operations). The company completed significant investment activities including redemption of ₹48 crore debentures and new AIF investments of ₹29.11 crores.
Ind-Swift Laboratories Reports Strong Q3FY26 Performance with Net Profit of ₹1074.18 Lakhs
